Large clonal outbreak of multidrug-resistant CC17 ST17 Enterococcus faecium containing Tn5382 in a Spanish hospital

Sylvia Valdezate1, Cristina Labayru, Ana Navarro

  • 1Departamento de Bacteriología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain. svaldezate@isciii.es

Abstract

Insights

A clonal outbreak of multidrug-resistant Enterococcus faecium (CC17 ST17) carrying Tn5382 was identified in a Spanish hospital. This persistent clone, found in both hospital and community settings, may increase vancomycin-resistant enterococci prevalence.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Enterococcus faecium is a significant cause of hospital-acquired infections.
  • Multidrug resistance in E. faecium, particularly vancomycin resistance, poses a major public health threat.
  • Clonal spread of specific E. faecium strains contributes to the dissemination of antibiotic resistance.

Purpose of the Study:

  • To characterize a large clonal outbreak of multidrug-resistant Enterococcus faecium (E. faecium) in a Spanish hospital.
  • To investigate the genetic basis of antibiotic resistance and virulence in the outbreak strain.
  • To assess the potential impact of this clone on the prevalence of vancomycin-resistant enterococci.

Main Methods:

  • Molecular typing of E. faecium isolates using pulsed-field gel electrophoresis (PFGE), multiple-locus variable-number tandem-repeat analysis (MLVA), and multilocus sequence typing (MLST).
  • Analysis of genes encoding resistance to ampicillin, aminoglycosides, macrolides, quinupristin/dalfopristin, quinolones, and tetracycline.
  • Identification and characterization of mobile genetic elements, including Tn5382, and virulence factors such as esp and hyl.

Main Results:

  • All isolates belonged to a single clone, identified as CC17 ST17 by MLST and MT1 by MLVA, exhibiting highly similar PFGE profiles.
  • The vancomycin-resistant E. faecium isolates carried the Tn5382 element linked to the pbp5 gene, with specific mutations in the vanS(B)-vanY(B) intergenic region.
  • Multiple resistance genes (erm(B), mef(E), tet(M), ant(6')-Ia, aph(3')-IIIa, aac(6')-Ie-aph(2'')-Ia) were identified, along with high-level ciprofloxacin resistance due to specific mutations in ParC and GyrA. The esp gene was universally present, while hyl was variable.

Conclusions:

  • A large clonal outbreak caused by multidrug-resistant CC17 E. faecium harboring pbp5-Tn5382 was described.
  • The persistence of this clone since 2005 in both hospital and community settings, coupled with the potential transfer of Tn5382 to other epidemic strains, may increase vancomycin-resistant enterococci prevalence.
  • This study reports the first description of the mef(E) gene in E. faecium.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...